Global Animal Medication Market to Reach $45.9 Billion by 2030
The global market for Animal Medication estimated at US$32.1 Billion in the year 2022, is projected to reach a revised size of US$45.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Companion Animals, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$20.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cattle Farm Animals segment is readjusted to a revised 3.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $8.7 Billion, While China is Forecast to Grow at 7.7% CAGR
The Animal Medication market in the U.S. is estimated at US$8.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.Select Competitors (Total 63 Featured) -
- Bayer AG
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale S.A.
- Dechra Pharmaceuticals Plc.
- Eli Lilly and Company
- Merck Animal Health
- Vetericyn Inc.
- Vétoquinol SA
- Virbac SA
- Zoetis Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale S.A.
- Dechra Pharmaceuticals Plc.
- Eli Lilly and Company
- Merck Animal Health
- Vetericyn Inc.
- Vétoquinol SA
- Virbac SA
- Zoetis Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 284 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 32.1 Billion |
Forecasted Market Value ( USD | $ 45.9 Billion |
Compound Annual Growth Rate | 4.6% |
Regions Covered | Global |